Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by Fudan University.
Recruitment status was  Recruiting
Information provided by:
Fudan University Identifier:
First received: December 26, 2007
Last updated: April 17, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):